Profile of prescription errors of compounding medications in a scholl pharmacy

Detalhes bibliográficos
Autor(a) principal: Alves, Felipe Cárdia
Data de Publicação: 2019
Outros Autores: Passos, Márcia Maria Barros dos, Melo, Adriana Silveira Pereira de, Monteiro, Mariana Sato de Souza Bustamante
Tipo de documento: Artigo
Idioma: por
eng
Título da fonte: Vigilância Sanitária em Debate
Texto Completo: https://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/article/view/1194
Resumo: Introduction: The manipulated medicinal product is a masterly preparation individualized to a patient from a prescription. Objective: To evaluate prescriptions at a compounding pharmacy of a federal public university in Rio de Janeiro, and to evaluate compliance with these prescriptions, in relation to the current technical-sanitary criteria. Method: This is a descriptive cross-sectional study, which evaluated 400 prescriptions in May 2015. Results: About 162 (40,00%) prescriptions presented errors, of which 132 showed exclusively bookkeeping errors, 20 exclusively, pharmacotechnical errors, and 10 both errors. Among the errors in bookkeeping, the most frequent were absence of date of issue (29%) and posology (13,00%). Among the pharmacotechnical errors, 66.33% were of incompatibility between the active and formulation, 13.33% were incompatibilities between different active in the same formulation and 23.33% were incompatibilities of the active with the semi-solid vehicle. Therefore, it was possible to identify that the prescriptions analyzed did not adequately comply with the Brazilian legislation, as errors were verified in both bookkeeping and pharmacotechnical aspects. Conclusions: Because they are manipulated drugs, which must be developed through a prescription, it is essential to carefully evaluate them to minimize or avoid damages to users.
id FIOCRUZ-9_58b9a459db22a17da4849dc1b60e6385
oai_identifier_str oai:ojs.visaemdebate.incqs.fiocruz.br:article/1194
network_acronym_str FIOCRUZ-9
network_name_str Vigilância Sanitária em Debate
repository_id_str
spelling Profile of prescription errors of compounding medications in a scholl pharmacyPerfil dos erros de prescrições de medicamentos manipulados em uma farmácia-escolaDrugs PrescriptionPharmaceutical CompoundingPharmacoepidemiologyPrescrição de MedicamentosFarmácia com ManipulaçãoFarmacoepidemiologiaIntroduction: The manipulated medicinal product is a masterly preparation individualized to a patient from a prescription. Objective: To evaluate prescriptions at a compounding pharmacy of a federal public university in Rio de Janeiro, and to evaluate compliance with these prescriptions, in relation to the current technical-sanitary criteria. Method: This is a descriptive cross-sectional study, which evaluated 400 prescriptions in May 2015. Results: About 162 (40,00%) prescriptions presented errors, of which 132 showed exclusively bookkeeping errors, 20 exclusively, pharmacotechnical errors, and 10 both errors. Among the errors in bookkeeping, the most frequent were absence of date of issue (29%) and posology (13,00%). Among the pharmacotechnical errors, 66.33% were of incompatibility between the active and formulation, 13.33% were incompatibilities between different active in the same formulation and 23.33% were incompatibilities of the active with the semi-solid vehicle. Therefore, it was possible to identify that the prescriptions analyzed did not adequately comply with the Brazilian legislation, as errors were verified in both bookkeeping and pharmacotechnical aspects. Conclusions: Because they are manipulated drugs, which must be developed through a prescription, it is essential to carefully evaluate them to minimize or avoid damages to users.Introdução: O medicamento manipulado é uma preparação magistral individualizada a um paciente a partir de uma prescrição. Objetivo: Avaliar as prescrições atendidas em uma farmácia com manipulação de uma universidade pública federal no Rio de Janeiro e avaliar o cumprimento destas prescrições, em relação aos critérios técnico-sanitários vigentes. Método: Estudo transversal descritivo no período do mês de maio de 2015, que avaliou 400 prescrições atendidas no período. Resultados: Cerca de 162 (40,00%) prescrições apresentaram erros, das quais 132 prescrições mostraram, exclusivamente, erros de escrituração, 20 exclusivamente erros farmacotécnicos e 10 ambos os erros. Dentre os erros de escrituração, os mais frequentes foram ausência de data de emissão (29,00%) e posologia (13,00%). Entre os erros farmacotécnicos, 66,33% foram de incompatibilidade entre o ativo e formulação, 13,33% foram incompatibilidades entre diferentes ativos de uma mesma formulação e 23,33% foram incompatibilidades do ativo com a base semissólida prescrita. Portanto, foi possível identificar que as prescrições analisadas não atenderam adequadamente ao estabelecido na legislação brasileira, pois verificou-se erros tanto dos aspectos da escrituração quanto farmacotécnico. Conclusões: Por se tratarem de medicamentos magistrais, os quais devem ser desenvolvidos mediante uma prescrição, torna-se fundamental a avaliação criteriosa para minimizar ou evitar danos aos usuários.Instituto Nacional de Controle de Qualidade em Saúde2019-02-28info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersion"Peer-reviewed article""Artículo revisado por pares""Artigo avaliado pelos pares"application/pdfapplication/pdfhttps://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/article/view/119410.22239/2317-269X.01194Health Surveillance under Debate: Society, Science & Technology ; Vol. 7 No. 1 (2019): February; 5-13Vigilancia en Salud en Debate: Sociedad, Ciencia y Tecnología; Vol. 7 Núm. 1 (2019): Febrero; 5-13Vigil Sanit Debate, Rio de Janeiro; v. 7 n. 1 (2019): Fevereiro; 5-132317-269Xreponame:Vigilância Sanitária em Debateinstname:Fundação Oswaldo Cruz (FIOCRUZ)instacron:FIOCRUZporenghttps://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/article/view/1194/988https://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/article/view/1194/1078Copyright (c) 2019 Vigilância Sanitária em Debate: Sociedade, Ciência & Tecnologia (Health Surveillance under Debate: Society, Science & Technology) – Visa em Debatehttps://creativecommons.org/licenses/by-nc-nd/4.0info:eu-repo/semantics/openAccessAlves, Felipe CárdiaPassos, Márcia Maria Barros dosMelo, Adriana Silveira Pereira deMonteiro, Mariana Sato de Souza Bustamante2023-06-27T16:49:42Zoai:ojs.visaemdebate.incqs.fiocruz.br:article/1194Revistahttps://visaemdebate.incqs.fiocruz.br/index.php/visaemdebatePUBhttps://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/oaiincqs.visaemdebate@fiocruz.br || gisele.neves@fiocruz.br2317-269X2317-269Xopendoar:2023-06-27T16:49:42Vigilância Sanitária em Debate - Fundação Oswaldo Cruz (FIOCRUZ)false
dc.title.none.fl_str_mv Profile of prescription errors of compounding medications in a scholl pharmacy
Perfil dos erros de prescrições de medicamentos manipulados em uma farmácia-escola
title Profile of prescription errors of compounding medications in a scholl pharmacy
spellingShingle Profile of prescription errors of compounding medications in a scholl pharmacy
Alves, Felipe Cárdia
Drugs Prescription
Pharmaceutical Compounding
Pharmacoepidemiology
Prescrição de Medicamentos
Farmácia com Manipulação
Farmacoepidemiologia
title_short Profile of prescription errors of compounding medications in a scholl pharmacy
title_full Profile of prescription errors of compounding medications in a scholl pharmacy
title_fullStr Profile of prescription errors of compounding medications in a scholl pharmacy
title_full_unstemmed Profile of prescription errors of compounding medications in a scholl pharmacy
title_sort Profile of prescription errors of compounding medications in a scholl pharmacy
author Alves, Felipe Cárdia
author_facet Alves, Felipe Cárdia
Passos, Márcia Maria Barros dos
Melo, Adriana Silveira Pereira de
Monteiro, Mariana Sato de Souza Bustamante
author_role author
author2 Passos, Márcia Maria Barros dos
Melo, Adriana Silveira Pereira de
Monteiro, Mariana Sato de Souza Bustamante
author2_role author
author
author
dc.contributor.author.fl_str_mv Alves, Felipe Cárdia
Passos, Márcia Maria Barros dos
Melo, Adriana Silveira Pereira de
Monteiro, Mariana Sato de Souza Bustamante
dc.subject.por.fl_str_mv Drugs Prescription
Pharmaceutical Compounding
Pharmacoepidemiology
Prescrição de Medicamentos
Farmácia com Manipulação
Farmacoepidemiologia
topic Drugs Prescription
Pharmaceutical Compounding
Pharmacoepidemiology
Prescrição de Medicamentos
Farmácia com Manipulação
Farmacoepidemiologia
description Introduction: The manipulated medicinal product is a masterly preparation individualized to a patient from a prescription. Objective: To evaluate prescriptions at a compounding pharmacy of a federal public university in Rio de Janeiro, and to evaluate compliance with these prescriptions, in relation to the current technical-sanitary criteria. Method: This is a descriptive cross-sectional study, which evaluated 400 prescriptions in May 2015. Results: About 162 (40,00%) prescriptions presented errors, of which 132 showed exclusively bookkeeping errors, 20 exclusively, pharmacotechnical errors, and 10 both errors. Among the errors in bookkeeping, the most frequent were absence of date of issue (29%) and posology (13,00%). Among the pharmacotechnical errors, 66.33% were of incompatibility between the active and formulation, 13.33% were incompatibilities between different active in the same formulation and 23.33% were incompatibilities of the active with the semi-solid vehicle. Therefore, it was possible to identify that the prescriptions analyzed did not adequately comply with the Brazilian legislation, as errors were verified in both bookkeeping and pharmacotechnical aspects. Conclusions: Because they are manipulated drugs, which must be developed through a prescription, it is essential to carefully evaluate them to minimize or avoid damages to users.
publishDate 2019
dc.date.none.fl_str_mv 2019-02-28
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
"Peer-reviewed article"
"Artículo revisado por pares"
"Artigo avaliado pelos pares"
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/article/view/1194
10.22239/2317-269X.01194
url https://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/article/view/1194
identifier_str_mv 10.22239/2317-269X.01194
dc.language.iso.fl_str_mv por
eng
language por
eng
dc.relation.none.fl_str_mv https://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/article/view/1194/988
https://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/article/view/1194/1078
dc.rights.driver.fl_str_mv https://creativecommons.org/licenses/by-nc-nd/4.0
info:eu-repo/semantics/openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by-nc-nd/4.0
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
application/pdf
dc.publisher.none.fl_str_mv Instituto Nacional de Controle de Qualidade em Saúde
publisher.none.fl_str_mv Instituto Nacional de Controle de Qualidade em Saúde
dc.source.none.fl_str_mv Health Surveillance under Debate: Society, Science & Technology ; Vol. 7 No. 1 (2019): February; 5-13
Vigilancia en Salud en Debate: Sociedad, Ciencia y Tecnología; Vol. 7 Núm. 1 (2019): Febrero; 5-13
Vigil Sanit Debate, Rio de Janeiro; v. 7 n. 1 (2019): Fevereiro; 5-13
2317-269X
reponame:Vigilância Sanitária em Debate
instname:Fundação Oswaldo Cruz (FIOCRUZ)
instacron:FIOCRUZ
instname_str Fundação Oswaldo Cruz (FIOCRUZ)
instacron_str FIOCRUZ
institution FIOCRUZ
reponame_str Vigilância Sanitária em Debate
collection Vigilância Sanitária em Debate
repository.name.fl_str_mv Vigilância Sanitária em Debate - Fundação Oswaldo Cruz (FIOCRUZ)
repository.mail.fl_str_mv incqs.visaemdebate@fiocruz.br || gisele.neves@fiocruz.br
_version_ 1797042045284515840